Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function

Inclusion Criteria: * Adult male and female subjects ≥18 to ≤75 years of age * Body mass index ≥18.0 to ≤36.0 kg/m2, at Screening * Subjects with mild, moderate, or severe renal impairment, or ESRD requiring HD * Control group of matched healthy subjects * Willing and able to provide written informed consent Exclusion Criteria: * Presence of clinically significant physical, laboratory, or ECG findings that may interfere with any aspect of study conduct or interpretation of results * Existence of any surgical or medical condition that might interfere with the absorption, distribution, metabolism, or excretion of sotagliflozin * History of any major surgery within 6 months * History of hepatic disease, or significantly abnormal liver function test * Women who are breastfeeding or are planning to become pregnant during the study